Eylea Biosimilar Gains UK/EEA Launch Dates
January 30, 2026
ADVANZ and Alvotech settle Eylea patents with Bayer/Regeneron, enabling UK launch Jan 1 2026 and EEA/Switzerland May 1 2026.
January 30, 2026
ADVANZ and Alvotech settle Eylea patents with Bayer/Regeneron, enabling UK launch Jan 1 2026 and EEA/Switzerland May 1 2026.